HomeCompareNAPRF vs JNJ

NAPRF vs JNJ: Dividend Comparison 2026

NAPRF yields 0.61% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NAPRF wins by $997.0K in total portfolio value
10 years
NAPRF
NAPRF
● Live price
0.61%
Share price
$48.81
Annual div
$0.30
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.03M
Annual income
$780,211.21
Full NAPRF calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — NAPRF vs JNJ

📍 NAPRF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNAPRFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NAPRF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NAPRF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NAPRF
Annual income on $10K today (after 15% tax)
$51.57/yr
After 10yr DRIP, annual income (after tax)
$663,179.53/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, NAPRF beats the other by $659,193.54/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NAPRF + JNJ for your $10,000?

NAPRF: 50%JNJ: 50%
100% JNJ50/50100% NAPRF
Portfolio after 10yr
$528.8K
Annual income
$392,450.31/yr
Blended yield
74.22%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

NAPRF
No analyst data
Altman Z
2.8
Piotroski
6/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NAPRF buys
0
JNJ buys
8
PoliticianChamberTickerTypeAmountDate
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002026-01-23
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-12-18
Lloyd Doggett🏢 House$JNJ▲ Buy$1,001 - $15,0002025-12-09
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002025-11-20
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-11-13
Rich McCormick🏢 House$JNJ▲ Buy$1,001 - $15,0002025-11-05
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Jared Moskowitz🏢 House$JNJ▼ Sell$1,001 - $15,0002025-10-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNAPRFJNJ
Forward yield0.61%2.13%
Annual dividend / share$0.30$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%28%
Portfolio after 10y$1.03M$30.3K
Annual income after 10y$780,211.21$4,689.40
Total dividends collected$985.4K$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: NAPRF vs JNJ ($10,000, DRIP)

YearNAPRF PortfolioNAPRF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,821$121.35$10,592$272.30+$229.00NAPRF
2$11,824$245.46$11,289$357.73+$535.00NAPRF
3$13,153$501.32$12,123$472.89+$1.0KNAPRF
4$15,116$1,042.37$13,141$629.86+$2.0KNAPRF
5$18,414$2,239.14$14,408$846.81+$4.0KNAPRF
6$24,801$5,098.24$16,021$1,151.60+$8.8KNAPRF
7$39,372$12,834.91$18,122$1,588.22+$21.3KNAPRF
8$80,213$38,085.30$20,930$2,228.20+$59.3KNAPRF
9$230,860$145,031.82$24,792$3,191.91+$206.1KNAPRF
10$1,027,231$780,211.21$30,274$4,689.40+$997.0KNAPRF

NAPRF vs JNJ: Complete Analysis 2026

NAPRFStock

Naspers Limited operates in the consumer internet industry worldwide. It operates through Classifieds, Food Delivery, Payments and Fintech, Etail, Edtech, and Other Ecommerce segments. It holds investments in classifieds, food delivery, payments and fintech, education, health, and ecommerce, as well as ventures, and social and internet platforms; and offers eMAG platform for online food and grocery delivery network. The company also prints, publishes, and distributes newspapers, magazines, and books through digital platforms, as well as provides media logistics. Naspers Limited was founded in 1915 and is headquartered in Cape Town, South Africa.

Full NAPRF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this NAPRF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NAPRF vs SCHDNAPRF vs JEPINAPRF vs ONAPRF vs KONAPRF vs MAINNAPRF vs ABBVNAPRF vs MRKNAPRF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.